Neurology News

NEW ORLEANS – A number of new treatments are on the horizon for PTSD, making the future bright for patients with this condition, Charles B. Nemeroff, MD, PhD, said at the American Psychiatric Association annual meeting.

Compared with infants born before the COVID-19 pandemic, those born during the pandemic had decreased fetal brain development, which researchers found was linked to higher levels of distress in women giving birth during the pandemic.

Prenatal exposure to topiramate, valproate and select duotherapies was associated with increased risk for autism spectrum disorder and intellectual disability, according to a study published in JAMA Neurology.

VeriSIM Life announced it will partner with neuroscience firm Total Brain to develop new drugs for the treatment of a wide range of neurological disorders, the company announced through a press release.

In the last 12 months, there has been a plethora of factors that have inched up the consumer price index, the key gauge the Federal Reserve uses as a barometer of inflation.

NIH researchers using machine learning models identified key characteristics of people who have or likely have long COVID.

HHS announced that Medicare Part B premiums paid in 2022 should be lowered in 2023 to account for an overestimate in costs related to inclusion of Aduhelm within the Medicare program for reimbursement.

Genentech announced that the FDA approved a label extension for Evrysdi to include infants younger than 2 months with spinal muscular atrophy.

Among patients with cryptogenic stroke, ipsilateral complicated carotid artery plaque detected by MRI was associated with elevated risk for recurrent ischemic stroke or transient ischemic attack, data show.

Seizure- and epilepsy-related emergency department visits decreased during the COVID-19 pandemic compared with pre-pandemic levels, with the largest drop seen among young children, per a study in MMWR.